Working... Menu

Use-Results Surveillance Study of Sovaldi® Plus Rebetol® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02562742
Recruitment Status : Completed
First Posted : September 29, 2015
Last Update Posted : August 1, 2017
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Gilead Sciences

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 12, 2017
  Actual Study Completion Date : June 12, 2017